310 related articles for article (PubMed ID: 18781150)
1. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
Panse J; Friedrichs K; Marx A; Hildebrandt Y; Luetkens T; Barrels K; Horn C; Stahl T; Cao Y; Milde-Langosch K; Niendorf A; Kröger N; Wenzel S; Leuwer R; Bokemeyer C; Hegewisch-Becker S; Atanackovic D
Br J Cancer; 2008 Sep; 99(6):930-8. PubMed ID: 18781150
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
3. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
Singh S; Singh R; Singh UP; Rai SN; Novakovic KR; Chung LW; Didier PJ; Grizzle WE; Lillard JW
Int J Cancer; 2009 Nov; 125(10):2288-95. PubMed ID: 19610059
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma.
Singh R; Gupta P; Kloecker GH; Singh S; Lillard JW
Int J Oncol; 2014 Dec; 45(6):2232-40. PubMed ID: 25271023
[TBL] [Abstract][Full Text] [Related]
6. The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.
Chen L; Huang Z; Yao G; Lyu X; Li J; Hu X; Cai Y; Li W; Li X; Ye C
J Transl Med; 2015 May; 13():168. PubMed ID: 25990390
[TBL] [Abstract][Full Text] [Related]
7. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
[TBL] [Abstract][Full Text] [Related]
13. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
[TBL] [Abstract][Full Text] [Related]
14. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
15. CXCL13/CXCR5 are potential biomarkers for diagnosis and prognosis for breast cancer.
Jiang L; Wang D; Sheng M; Tong D; Liu H; Dong L; Ma J
J BUON; 2020; 25(6):2552-2561. PubMed ID: 33455096
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy.
Mao Y; Wang M; Zhou Q; Jin J; Wang Y; Peng W; Wu J; Shou Z; Chen J
J Clin Immunol; 2011 Jun; 31(3):414-8. PubMed ID: 21191639
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
19. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
[TBL] [Abstract][Full Text] [Related]
20. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
